Autologous Bone Marrow Cell Infusion for the Treatment of Decompensated Liver Cirrhosis Patients With Type 2 Diabetes Mellitus
This study aimed to indicate whether autologous bone marrow cell infusion (ABMI) via the right omental vein (ROV) could have a regulatory effect on decompensated liver cirrhosis (DLC) patients with type 2 diabetes mellitus (T2DM). For this purpose, 24 DLC patients with T2DM were divided into observa...
Saved in:
Main Authors: | Baochi Liu, Mingrong Cheng, Lin Lang, Lei Li, Yanhui Si, Guangmian Wang |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/058bde326aaf4c05a60d97ed690c01eb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sequential Changes in the Mesenteric Lymph Node Microbiome and Immune Response during Cirrhosis Induction in Rats
by: Alba Santiago, et al.
Published: (2019) -
Proton Pump Inhibitor Therapy Does Not Affect Prognosis of Cirrhosis Patients With Acute Decompensation and Acute-on-Chronic Liver Failure: A Single-Center Prospective Study
by: Shanshan Sun, et al.
Published: (2021) -
Step by Step: Managing the Complications of Cirrhosis
by: Perez IC, et al.
Published: (2021) -
Management of Ascites in Patients with Cirrhosis: An Update
by: Giacomo Zaccherini, et al.
Published: (2021) -
Bone marrow research
Published: (2011)